ghres.com (GHRS) Earnings growth forecast for next year

Graphic logo of ghres.com (GHRS)

The dynamics of forward EPS estimates reflect the earnings expectations for GH Research PLC. The biotech firm is developing a unique, ultra-fast inhalational antidepressant with high demand. Intellectual property rights will enable global scaling and massive margins. While the startup currently relies on investment, its patents will provide pricing power. The value of -59.40 determines the latest valuation metric for this asset.

GH Research plc (GHRS): Expected net earnings per share growth next year from 07/04/2022 to 11/15/2026

GH Research Corp - analytical breakdowns and key metrics (GHRS)

- share price and consensus valuation forecast:
Fundamental company valuation:GHRS, GH Research PLC
Finished products of GH Research plc

The assessment of the asset's operational resilience is based on an analysis of consensus earnings per share forecasts, where the projected EPS growth rate reflects the business's sensitivity to market shocks and the revaluation of future cash flows. For GH Research PLC (GHRS), with its patented therapies for depression, this metric confirms the ability to capitalize on its monopoly status to drive long-term growth in free cash flow.